glp-1 for hypothyroidism GLP-1RA and thyroid cancer: New study suggests detection bias, not causation GLP-1 medications can be powerful
Description
The Phase 3 ATTAIN-1 trial had good results that led to this approval, but not all positive: 12.4% average weight loss (27.3 lbs) at highest dose Lower than the 15-20% weight loss seen with injectables Wegovy and Zepbound Nearly 1/4 of participants on the highest dose reported vomiting Vomiting rates are much higher than injectable GLP-1s However, there is likely a niche for Foundayo (along with the pill version of Wegovy) due to convenience: No refrigeration requirements or injection site reactions Eliminates barriers for patients avoiding injectables due to stigma, needle aversion, or storage constraints It's possible we could see this as a "maintenance" therapy after an initial injectable course
The Elo GLP-1 Muscle Retention Protein is doctor-formulated to work with reduced appetite

Preclinical studies suggest that GIPR antagonism helps with weight loss and metabolic improvements

A real look at my experience with Oce Aura patches and their role in curbing cravings.

Discover Semaglutide at Scale Watchers RX in Nashville for effective, cheap weight loss solutions

This was a retrospective cohort study of adult patients with a body mass index (BMI)30kg/m2 prescribed GLP-1 analogue therapy at an obesity specialist clinic in Vancouver, Canada